NCT06926777

Brief Summary

Comparative Analysis of Median Nerve Parameters for Carpal Tunnel Syndrome (CTS) Diagnosis: Ultrasound vs. Nerve Conduction Study (NCS) This clinical study aims to determine whether ultrasound can be as practical as NCS in diagnosing CTS. It will also evaluate the accuracy of different median nerve measurements in both tests. The main questions it aims to answer are: Can ultrasound accurately detect CTS compared to NCS? Which median nerve measurements (such as size, speed, or function) are most useful for diagnosis? Researchers will compare ultrasound and NCS results in patients with CTS symptoms to determine which test is more reliable and patient-friendly. Participants will:

  1. 1.Undergo both an ultrasound and a NCS for comparison.
  2. 2.Visit the clinic for testing and evaluation as part of the study.
  3. 3.Provide information about their symptoms and medical history related to CTS. This study aims to improve diagnosis accuracy and explore whether ultrasound could be a more comfortable and quicker alternative to NCS for detecting CTS.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 15, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 15, 2025

Completed
16 days until next milestone

Study Start

First participant enrolled

May 1, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2025

Completed
Last Updated

April 15, 2025

Status Verified

April 1, 2025

Enrollment Period

2 months

First QC Date

March 15, 2025

Last Update Submit

April 11, 2025

Conditions

Keywords

Carpal Tunnel SyndromeNumbnessTinglingUltrasoundNerve Conduction StudyHand Weakness

Outcome Measures

Primary Outcomes (1)

  • Diagnostic Accuracy of Ultrasound Compared to Nerve Conduction Study for Carpal Tunnel Syndrome

    Measuring the sensitivity, specificity, and overall accuracy of ultrasound in diagnosing CTS compared to NCS Parameters, including Median Nerve Latency, Amplitude, and Nerve Conduction Velocity

    Baseline

Study Arms (2)

Ultrasound Diagnostic Arm

OTHER

Participants in this arm will undergo ultrasound imaging of the median nerve at the wrist. Measurements such as CSA and flattening ratio will be recorded. The goal is to evaluate ultrasound's effectiveness in diagnosing CTS compared to NCS.

Diagnostic Test: Nerve Conduction Study

Nerve Conduction Study (NCS) Group (Diagnostic Arm)

OTHER

Participants in this arm will undergo an NCS to assess median nerve function. Parameters such as nerve conduction velocity, latency, and amplitude will be recorded. NCS findings will serve as the gold standard for comparison with ultrasound results.

Diagnostic Test: Nerve Conduction Study

Interventions

Nerve Conduction StudyDIAGNOSTIC_TEST

This study involves two diagnostic interventions for evaluating CTS: Ultrasound Examination (Diagnostic Intervention) 1. A high-frequency ultrasound probe will be used to assess the median nerve at the wrist. 2. Parameters measured include cross-sectional area, flattening ratio, and echogenicity. The goal is to determine if ultrasound can accurately diagnose CTS compared to NCS. NCS (Diagnostic Intervention) 1. Surface electrodes will be placed on the skin to stimulate and record median nerve conduction. 2. Parameters such as latency, conduction velocity, and amplitude will be recorded. 3. NCS serves as the gold standard for diagnosing CTS and will be used for comparison with ultrasound results. Each participant will undergo both ultrasound and NCS, allowing researchers to compare their effectiveness in diagnosing CTS.

Nerve Conduction Study (NCS) Group (Diagnostic Arm)Ultrasound Diagnostic Arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18 years or older.
  • Patients with clinical symptoms of CTS, including numbness, tingling, pain, or weakness in the hand.
  • Positive findings on clinical examination, such as Tinel's sign, Phalen's test, or Durkan's test.
  • Willingness to undergo both ultrasound and NCS for diagnostic evaluation.

You may not qualify if:

  • Previous surgery for CTS in the affected hand.
  • History of peripheral neuropathy such as diabetic neuropathy
  • Other neuromuscular disorders affecting the upper limb such as cervical radiculopathy.
  • Pregnant women.
  • Severe comorbid conditions that may interfere with study participation.
  • Inability to provide informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Combined Military Hospital

Kohat, KPK, 26000, Pakistan

Location

MeSH Terms

Conditions

Carpal Tunnel SyndromeHypesthesiaParesthesia

Interventions

Nerve Conduction Studies

Condition Hierarchy (Ancestors)

Median NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNerve Compression SyndromesCumulative Trauma DisordersSprains and StrainsWounds and InjuriesSomatosensory DisordersSensation DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, NeurologicalDiagnostic Techniques and ProceduresDiagnosisElectrodiagnosis

Study Officials

  • Syed Tameem Ul Hassan, MBBS, FCPS

    Combined Military Hospital Kohat

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Syed Tameem Ul Hassan, MBBS, FCPS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

March 15, 2025

First Posted

April 15, 2025

Study Start

May 1, 2025

Primary Completion

July 1, 2025

Study Completion

July 1, 2025

Last Updated

April 15, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will share

Following IPD will be shared 1. De-identified demographic data that is age, gender, relevant medical history. 2. Ultrasound measurements of the median nerve such as CSA and flattening ratio. 3. NCS results such as latency, conduction velocity and amplitude. 4. Clinical assessment findings such as Tinel's sign, Phalen's test results.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
After the completion of study, data will be provided on demand and will be available for 6 months post completion.
Access Criteria
Researchers will be given access. Data will be shared via email.

Locations